Johns Creek Named First “BioReady Community” in Georgia

Mainstage at the GA Life Sciences Summit

As the life sciences sector in Georgia continues to grow at a rapid pace, the need for bioready sites grows. As just the second state in the country to formally adopt such a program, the BioReady Community program will allow Georgia’s municipalities to showcase biotech-zoned science parks, streamline permitting, build a robust infrastructure, and identify biotech-friendly sites more effectively in the interest of attracting companies interested in relocating. 

After lunch Maria announced that the City of Johns Creek is the first municipality in the state to achieve this designation.

Mainstage at the GA Life Sciences Summit

Johns Creek Mayor John Bradbury said, “We need to challenge each other. We can push the ball forward at a grassroots level .… And hopefully that’s going to mean a bigger ecosystem for this industry in our state.”

Given the industry’s large footprint in Georgia including 78,000 direct jobs across 4,000 establishments, nearly 215,000 total jobs and over $50 billion in economic impact, Georgia cities and towns are increasingly adopting local policies that greatly ease the pathway for renovation or new construction of biotech laboratory and manufacturing facilities.

Georgia Bio’s counterpart in Massachusetts, MassBio , has developed a rating system to determine a municipality’s readiness to host biotechnology facilities based on the community’s zoning practices and infrastructure capacity. BioReady® rates these communities in three tiers from Bronze to Gold. Through these BioReady® ratings, Georgia Bio seeks to provide cities and towns a platform to effectively tell their stories to the biotechnology industry that will ultimately help real estate developers and biotechnology companies find the most favorable destinations to locate.

AtlantaInno and Atlanta Business Chronicle Reporter Rebecca Grapevine noted , “Earlier this year, Johns Creek tallied a win when Boston Scientific Corp. (NYSE: BSX) committed to a nearly quarter-million-square-foot lease at the former State Farm campus. The expansion could bring up to 340 jobs, the company said.” [Note: subscription required.]

Click Here to View the Georgia BioReady Page & Learn How to Apply

—————————–

Below are Links to the John’s Creek Announcements

Mainstage at the GA Life Sciences Summit
By Maria Thacker Goethe October 22, 2025
“Evolving FTC and DOJ policies leave investors and innovators navigating a cautious M&A landscape
October 6, 2025
Atlanta, GA — October 6 — Georgia Life Sciences today announced the launch of Vitals, a new podcast series developed in partnership with Cloudcast Media, a leader in branded podcast production. The series will spotlight the people, ideas, and innovations shaping the future of Georgia’s rapidly growing life sciences sector. Hosted by Georgia Life Sciences’ CEO, Maria Thacker Goethe, Vitals will feature in-depth conversations with scientists, entrepreneurs, investors, educators, policymakers, and patient advocates. Each episode will explore the challenges and opportunities facing Georgia’s life sciences ecosystem—spanning biopharma, medical technology, digital health, and advanced manufacturing. “Vitals gives us a powerful platform to showcase the remarkable work happening within our state,” said Maria Thacker Goethe. “By sharing these stories, we’re highlighting not only groundbreaking science but also the collaboration and talent that make Georgia such a vibrant hub for health innovation.” Cloudcast Media, known for its expertise in storytelling and high-quality podcast production, will bring industry insights and technical support to ensure the series reaches audiences across Georgia and beyond. “We’re proud to partner with Georgia Life Sciences on Vitals,” said Charles Parisi, Founder and CEO of Cloudcast. “This series will elevate the voices of innovators who are advancing science, improving patient outcomes, and building Georgia’s reputation as a global life sciences leader. We are very excited that Cloudcast Atlanta can play a role in supporting Maria and the impactful work of Georgia Life Sciences.” The first episode of Vitals launched today and is available on Apple Podcasts, Spotify, and other major streaming platforms, as well as through the Georgia Life Sciences website.
October 1, 2025
September 30, 2025 WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO) released the following statement on Most Favored Nation policies: "For too many years, Americans have subsidized the research and development necessary to bring newer and better medicines to patients around the world. As we saw with defense spending and NATO, the solution is not to weaken a strategically important American industry, but for other countries to pay their fair share. “Today’s announcement in the Oval Office highlights the problems with a drug delivery system where half of the cost of innovative medicines goes to middlemen and distributors, and where the supply chain distorts prices paid by the American people. We support a new framework that addresses the cost of medicines by simplifying the system - and making medicines directly available to patients. “But importing socialist price controls through most-favored nation policies fundamentally does not address the imbalance in international pricing for innovative medicines. MFN will not lower the out-of-pocket prices that most Americans pay for medicines. Even worse, it will jeopardize the entrepreneurial spirit and deter the capital necessary for a vibrant and essential American biotechnology industry to thrive and may cause most harm to small and midsize biotech companies, which are responsible for discovering more than half of all new treatments. “Without these biotech innovators and a free-market system, we risk slower scientific progress, decreased access to new medicines, compromised national security, fewer American jobs and perhaps most tragically, a diminished hope for those suffering with illness and disease. There are much better ways to address this problem than MFN.” ###
MORE POSTS